A 3-year follow-up study of atropine treatment for progressive myopia in Europeans
SourceEye (The Royal College of Ophthalmologists), 34, 11, (2020), pp. 2020-2028
Article / Letter to editor
Display more detailsDisplay less details
Eye (The Royal College of Ophthalmologists)
SubjectRadboudumc 12: Sensory disorders DCMN: Donders Center for Medical Neuroscience
BACKGROUND: Atropine is the most powerful treatment for progressive myopia in childhood. This study explores the 3-year effectiveness of atropine in a clinical setting. METHODS: In this prospective clinical effectiveness study, children with progressive myopia≥1D/year or myopia≤ -2.5D were prescribed atropine 0.5%. Examination, including cycloplegic refraction and axial length (AL), was performed at baseline, and follow-up. Outcome measures were spherical equivalent (SER) and AL; annual progression of SER on treatment was compared with that prior to treatment. Adjustments to the dose were made after 1 year in case of low (AL≥0.3nmm/year) or high response (ALn<n0.1nmm/year) of AL. RESULTS: A total of 124 patients were enrolled in the study (median age: 9.5, range: 5-16 years). At baseline, median SER was -5.03D (interquartile range (IQR): 3.08); median AL was 25.14nmm (IQR: 1.30). Nn=n89 (71.8%) children were persistent to therapy throughout the 3-year follow-up. Median annual progression of SER for these children was -0.25D (IQR: 0.44); of AL 0.11nmm (IQR: 0.18). Of these, Nn=n32 (36.0%) had insufficient response and were assigned to atropine 1%; Nn=n26 (29.2%) showed good response and underwent tapering in dose. Rebound of AL progression was not observed. Of the children who ceased therapy, Nn=n9 were lost to follow-up; Nn=n9 developed an allergic reaction; and Nn=n17 (19.1%) stopped due to adverse events. CONCLUSION: In children with or at risk of developing high myopia, a starting dose of atropine 0.5% was associated with decreased progression in European children during a 3-year treatment regimen. Our study supports high-dose atropine as a treatment option for children at risk of developing high myopia in adulthood.
Upload full text